• Media type: E-Article
  • Title: First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies
  • Contributor: Weiss, Glen J.; Chao, Joseph; Neidhart, Jeffrey D.; Ramanathan, Ramesh K.; Bassett, Dawn; Neidhart, James A.; Choi, Chung Hang J.; Chow, Warren; Chung, Vincent; Forman, Stephen J.; Garmey, Edward; Hwang, Jungyeon; Kalinoski, D. Lynn; Koczywas, Marianna; Longmate, Jeffrey; Melton, Roger J.; Morgan, Robert; Oliver, Jamie; Peterkin, Joanna J.; Ryan, John L.; Schluep, Thomas; Synold, Timothy W.; Twardowski, Przemyslaw; Davis, Mark E.;
  • imprint: Springer Science and Business Media LLC, 2013
  • Published in: Investigational New Drugs
  • Language: English
  • DOI: 10.1007/s10637-012-9921-8
  • ISSN: 0167-6997; 1573-0646
  • Origination:
  • Footnote: